Gene Editing Market Share, Size, and Trends by 2030
Gene Editing Market: Strategic Insights
Gene Editing Market
-
CAGR (2022 - 2030)17.6% -
Market Size 2022
US$ 6,542.95 Million -
Market Size 2030
US$ 23,902.34 Million
Market Dynamics
GROWTH DRIVERS
- Technological advancements in CRISPR technology
- Rising focus on personalized medicine
- Growing funding for gene therapy research
FUTURE TRENDS
- Rising use of CRISPR technology in clinical applications
- Increased focus on gene therapies for rare diseases
- Technological advancements in precision medicine
OPPORTUNITIES
- Expanding research in gene therapies for inherited diseases
- Rising investment in gene editing clinical trials
- Growing regulatory support for gene-editing applications
Key Players
- Thermo Fisher Scientific
- GenScript
- Lonza
- Merck KGaA
- CRISPR Therapeutics
- PerkinElmer Inc
- Agilent Technologies Inc
- Precision Biosciences
- Sangamo Therapeutics Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Component
- Reagents and Consumables
- Software and Systems
- Services
Technology
- Clustered Regularly Interspaced Short Palindromic Repeats
- Transcription Activator-Like Effector Nucleases
- Zinc Finger Nucleases
- Other Technologies
Application
- Genetic Engineering and Clinical Applications
End User
- Pharmaceutical companies and Biotechnology Companies
- Academics and Government Research Institutes
- Clinical Research Organizations